MicroPort NeuroTech Limited (HK:2172) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MicroPort NeuroTech Limited reported a significant 36.4% revenue increase in the first half of 2024, driven by successful overseas expansion, growing market share of intracranial atherosclerotic stenosis products, and strong sales of coil products and new stroke and access products. The company’s revenue surge was particularly marked by an 87% jump in international sales compared to the prior year. Additionally, MicroPort NeuroTech has announced its plans to distribute an interim dividend of HK$0.08 per share to its shareholders.
For further insights into HK:2172 stock, check out TipRanks’ Stock Analysis page.